{"id":812571,"date":"2025-02-13T06:15:53","date_gmt":"2025-02-13T11:15:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/"},"modified":"2025-02-13T06:15:53","modified_gmt":"2025-02-13T11:15:53","slug":"beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/","title":{"rendered":"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27<\/b><\/p>\n<p>SAN MATEO, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.beigene.com&amp;esheet=54205402&amp;newsitemid=20250213264583&amp;lan=en-US&amp;anchor=BeiGene%2C+Ltd.&amp;index=1&amp;md5=8f82313aa06c86063bc88a7c414b74f7\">BeiGene, Ltd.<\/a> (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., will report its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 before the financial markets open. Following the release of the financials, the Company will host a live webcast with BeiGene management at 8:00 a.m. ET.<\/p>\n<p>\nThe conference call will be webcast live and a link to the webcast can be accessed from the investors section of BeiGene\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fir.beigene.com%2F&amp;esheet=54205402&amp;newsitemid=20250213264583&amp;lan=en-US&amp;anchor=http%3A%2F%2Fir.beigene.com%2F&amp;index=2&amp;md5=4d87c85113121adb8de28d36c37401f0\">http:\/\/ir.beigene.com\/<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fhkexir.beigene.com%2F&amp;esheet=54205402&amp;newsitemid=20250213264583&amp;lan=en-US&amp;anchor=https%3A%2F%2Fhkexir.beigene.com%2F&amp;index=3&amp;md5=8d43fc02d9decec0468c120648fe67de\">https:\/\/hkexir.beigene.com\/<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsseir.beigene.com%2F&amp;esheet=54205402&amp;newsitemid=20250213264583&amp;lan=en-US&amp;anchor=https%3A%2F%2Fsseir.beigene.com%2F&amp;index=4&amp;md5=1ac53a2a8749b6cb18ac17fb8d44cfa4\">https:\/\/sseir.beigene.com\/<\/a>. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company&#8217;s website.<\/p>\n<p><b>About BeiGene<\/b><\/p>\n<p>\nBeiGene, which plans to change its name to BeOne Medicines, is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of nearly 11,000 colleagues spans five continents. To learn more about BeiGene, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.beigene.com&amp;esheet=54205402&amp;newsitemid=20250213264583&amp;lan=en-US&amp;anchor=www.beigene.com&amp;index=5&amp;md5=29a0eb672fc7567e9a60a01a0a4ed8b1\">www.beigene.com<\/a> and follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbeigene%2F&amp;esheet=54205402&amp;newsitemid=20250213264583&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=6&amp;md5=464a6b6f8892d291f3c6d05d0e631104\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fx.com%2Fbeigeneglobal&amp;esheet=54205402&amp;newsitemid=20250213264583&amp;lan=en-US&amp;anchor=X&amp;index=7&amp;md5=4dac4d3cbb473ed673e77ea797b16ef3\">X<\/a> (formerly known as Twitter), <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FBeiGeneGlobal%2F&amp;esheet=54205402&amp;newsitemid=20250213264583&amp;lan=en-US&amp;anchor=Facebook&amp;index=8&amp;md5=fa3f7009984d12aafc4b544690c6be83\">Facebook<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2FBeiGeneGlobal%2F&amp;esheet=54205402&amp;newsitemid=20250213264583&amp;lan=en-US&amp;anchor=Instagram&amp;index=9&amp;md5=d3d1ab70c1807c91e506ca00303876a8\">Instagram<\/a>.<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nThis presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeiGene&#8217;s plans, commitments, aspirations and goals related to BeiGene\u2019s medicines and drug candidates. Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors which are discussed in the section entitled \u201cRisk Factors\u201d in BeiGene\u2019s most recent periodic report filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) as well as discussions of potential risks, uncertainties, and other important factors in BeiGene&#8217;s subsequent filings with the SEC. All information in this presentation is as of the date presented, and BeiGene undertakes no duty to update such information unless required by law.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250213264583\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250213264583\/en\/<\/a><\/span><\/p>\n<p><b>Investors:<br \/>\n<\/b><br \/>Liza Heapes<br \/>\n<br \/>+1 857-302-5663<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@beigene.com\">ir@beigene.com<\/a><\/p>\n<p><b>Media:<br \/>\n<\/b><br \/>Kyle Blankenship<br \/>\n<br \/>+1 667-351-5176<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:media@beigene.com\">media@beigene.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250213264583\/en\/1612468\/3\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., will report its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 before the financial markets open. Following the release of the financials, the Company will host a live webcast with BeiGene management at 8:00 a.m. ET. The conference call will be webcast live and a link to the webcast can be accessed from the investors section of BeiGene\u2019s website at http:\/\/ir.beigene.com\/, https:\/\/hkexir.beigene.com\/, https:\/\/sseir.beigene.com\/. To ensure a timely connection, it is recommended that participants register at least &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-812571","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., will report its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 before the financial markets open. Following the release of the financials, the Company will host a live webcast with BeiGene management at 8:00 a.m. ET. The conference call will be webcast live and a link to the webcast can be accessed from the investors section of BeiGene\u2019s website at http:\/\/ir.beigene.com\/, https:\/\/hkexir.beigene.com\/, https:\/\/sseir.beigene.com\/. To ensure a timely connection, it is recommended that participants register at least &hellip; Continue reading &quot;BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-13T11:15:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27\",\"datePublished\":\"2025-02-13T11:15:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/\"},\"wordCount\":430,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/\",\"name\":\"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-02-13T11:15:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/","og_locale":"en_US","og_type":"article","og_title":"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 - Market Newsdesk","og_description":"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., will report its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 before the financial markets open. Following the release of the financials, the Company will host a live webcast with BeiGene management at 8:00 a.m. ET. The conference call will be webcast live and a link to the webcast can be accessed from the investors section of BeiGene\u2019s website at http:\/\/ir.beigene.com\/, https:\/\/hkexir.beigene.com\/, https:\/\/sseir.beigene.com\/. To ensure a timely connection, it is recommended that participants register at least &hellip; Continue reading \"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-13T11:15:53+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27","datePublished":"2025-02-13T11:15:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/"},"wordCount":430,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/","name":"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-02-13T11:15:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250213264583r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-27\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/812571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=812571"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/812571\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=812571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=812571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=812571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}